Specifically, a “suggestive” genetic association of NINJ2 variants with susceptibility to MS has been observed [22], as well as a different methylation state in CD4+ and CD8+ lymphocytes, coupled with a different NINJ2 expression, when comparing MS patients with HCs [23]. The gene discussed is NINJ2; the disease is myeloid sarcoma.